The invention provides compounds of formula (II), wherein Ar, R.sub.3, R.sub.4, R.sub.5, R.sub.6, R.sub.7, R.sub.8 and W have the meanings given in the description. They are selective MEK inhibitors. ##STR1##

L'invention fournit des composés de la formule (ii), où Ar, R.sub.3, R.sub.4, R.sub.5, R.sub.6, R.sub.7, R.sub.8 et W ont les significations données dans la description. Elles sont les inhibiteurs sélectifs de MEK. ## du ## STR1

 
Web www.patentalert.com

< (none)

< Substituted 2-(S)-hydroxy-3-(piperidin-4-yl-methylamino)-propyl ethers and substituted 2-aryl-2-(R)-hydroxy-1-(piperidin-4-yl-methyl)-ethylamine .beta.-3 adrenergic receptor agonists

> Use of a RAR-.gamma.-specific agonist ligand for increasing the rate of apoptosis

> (none)

~ 00057